Germany · Delayed Price · Currency is EUR Verbio SE Earnings Call Transcripts
Fiscal Year 2026
-
Strong Q3 results driven by higher production, robust GHG quota demand, and regulatory tailwinds. EBITDA guidance for FY 2025/2026 raised to the upper end of EUR 100–140 million, with net debt expected below EUR 140 million. Bioethanol margins outperformed biodiesel due to market dynamics.
-
Production volumes and CO2 savings are rising, with profitability recovering after regulatory improvements and market disruptions. International expansion and innovation in co-products and specialty chemicals drive future growth, while policy changes and market trends support strong biofuel demand.
-
Strong first-half results driven by higher production and improved market conditions, with EBITDA guidance raised to the upper end of the previous range. Regulatory changes in Germany and the U.S. are expected to further support margins, while strategic investments and expanded trading activities position the company for continued growth.
-
Record production in biodiesel, ethanol, and biomethane drove strong year-over-year earnings growth, with North American operations and favorable market spreads contributing positively. Guidance remains unchanged amid regulatory uncertainty, but upside potential exists if market conditions persist.
Fiscal Year 2025
-
Record production achieved despite market and regulatory headwinds, but earnings declined due to lower margins, fraud, and one-offs. Strategic projects in the U.S., Germany, and India are advancing, with guidance for improved EBITDA and cash flow in 2025-2026. Dividend suspended to maintain flexibility.
-
EBITDA declined sharply year-over-year due to weak margins and regulatory changes, but Q3 saw improvement in key segments. Investments and CapEx have been scaled back, with a focus on cash flow and operational efficiency. Market recovery is expected as regulatory and trade conditions evolve.
-
Record ethanol and RNG production offset by lower margins and technical issues in the U.S., leading to reduced EBITDA guidance. Biodiesel segment outperformed, while regulatory changes and market stabilization in Germany are expected to drive improvement in 2025.
-
Q1 saw a sharp EBITDA decline to -€6.6M despite higher production, driven by lower prices and GHG quota market challenges. Guidance is unchanged, with Q2 expected to improve and regulatory changes in Germany and India likely to support future growth.
Fiscal Year 2024
-
Record biofuel and RNG production drove strong CO2 savings, with EBITDA in line with revised guidance despite market and regulatory headwinds. Strategic investments in the US and Europe continue, while new German regulations and reduced Chinese imports are expected to improve future margins.